Blood arsenic and cadmium concentrations in end-stage renal disease patients who were on maintenance haemodialysis

Journal of Clinical and Diagnostic Research

Volumn 7, Issue 5, 2013, Pages 809-813

  Palaneeswari, M Subha ^a   Sam Rajan, P M Abraham ^b   Silambanan, Santhi ^c   Jothimalar, ^c  

^a SREE BALAJI MEDICAL COLLEGE AND HOSPITAL   (India)

^b SAVEETHA MEDICAL COLLEGE AND HOSPITAL   (India)

^c SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Arsenic; Cadmium; End stage renal disease; Maintenance haemodialysis

Indexed keywords

ARSENIC; CADMIUM;

ADULT; ARSENIC BLOOD LEVEL; ARTICLE; BIOACCUMULATION; CADMIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LEAD BLOOD LEVEL; LONG TERM EXPOSURE; MAINTENANCE THERAPY; MALE; TRACE METAL BLOOD LEVEL; TREATMENT DURATION; URINARY EXCRETION;

EID: 84877134801     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2013/5351.2945     Document Type: Article

References (42)

1. Braunwald, Fauci, Kasper, Hauser, Longo, Jameson. Disturbances of renal function. Harrison's Principles of Intenal Medicine. Mc Graw Hill Medical Publishing division. 2004;15th ed: 2: 1535-41.
2. Peter Soderland, Shachi Loverkar, Daniel E. Weiner et al. Chronic kidney disease associated with environmental toxins and exposures. Advancces in Chronic Kidney Disease. 2010, 17(3), 254-64. doi:10.1053/j.ackd. 2010.03.011.
3. Subha Palaneeswari, P.M. Abraham, Sam Rajan, et al. Blood lead level in end-stage renal disease patients on maintenance hemodialysis. Journal of Clinical and Diagnostics Research. 2012 Dec; 6 (10):1633-35.
4. Ja-Liang Lin, Dan-Tzu Lin Tan, Kuan-Hsing, Chen et al. Blood lead levels associated with 18-month all-cause mortality in patients with chronic peritoneal dialysis. Nephrol Dial Transplant. 2010;25:1627-33. doi: 10.1093/ndt/gfp663.
5. Pietro M Ferraro, Stefano Costanzi, Alessandro Naticchia, Antonio Sturniolo, Giovanni Gambaro. Low level exposure to cadmium increases the risk of chronic kidney disease: analysis of the NHANES 1999-2006. BMC Public Health. 2010;10: 304: 1471-2458. doi:10.1186/1471-2458-10-304.
6. Marcello Tonelli, Natasha Wiebe1, Brenda Hemmelgarn, et al. Trace elements in hemodialysis patients: a systematic review and meta-analysis. BMC Medicine. 2009;7:25. doi:10.1186/1741-7015-7-25.
7. Zima T, Tesar V, Mestek O, Nemecek K. Trace elements in end-stage renal disease. 2. Clinical implication of trace elements. Blood Purif. 1999;17(4).187-98.
8. Zima T, Mestek O, Nemecek K, et al. Trace elements in hemodialysis and continuous ambulatory peritoneal dialysis patients. Blood Purif. 1998;16:253-260. DOI: 10.1159/000014342.
9. Adrian Covic, Paul Gusbeth-Tatomir. Trace elements in end-stage renal disease-unfamiliar territory to be revealed. BMC Nephrology. 2009;10:12. doi:10.1186/1471-2369-10-12
10. Lotelli F, Covic A, Eckardt KU, Andrzej Wiecek, et al. Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). Nephrol Dial Transplant. 2009;24(2):348-54.
11. Kalantar-Zadeh K, Block G, Humphreys MH, et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int. 2003;63(3):793-808.
12. Lawrence JF, Michalik P, Tam G, et al. Identification of arsenobetaine and arsenocholine in Canadian fish and shellfish by high-performancae liquid chromatography with atomic absorption detection and confirmation by fast atom bombardment mass spectrometry. J Agri Food Chem. 1981;34:315-19.
13. Sanjay K. Agarwal, Suresh Candra Dash. Incidence of chronic kidney disease in India. Nephrl Dial Transplant. 2006;21:232
14. Meliker JR, Wahl RL, Cameron LL, et al. Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: A standardized mortality ratio analysis. Environ Health. 2007;6:4.
15. Chiou HY, Hsueh YM, Liaw KF, et al. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Research. 1995; 55:1296-1300.
16. Boffetta P, Nyberg F. Contribution of environmental factors to cancer risk. Br Med Bull. 2003; 68:71-94.
17. Rossman TG. Mechanism of arsenic carcinogenesis: An integrated approach. Mutat Res. 2003; 533:37-65.
18. Neuberger JS, Field RW. Occupation and lung cancer in nonsmokers. Rev Environ Health. 2003; 18:251-67.
19. Hsueh YM, Chung CJ, Shieu HS, et al. Urinary arsenic species and CKD in a Taiwanese population: a case-control study. Am J Kidney Dis. 2009; 54:859-70.
20. Van Renterghem D, R Cornelis, Vanholder R. Behaviour of 12 trace elements in serum of uremic patients on hemodiafiltration. J Trace Elem. Electrolytes Health Dis. 1992;6:169-74.
21. De Kimpe J, Cornelis R, Mees L, et al. More than ten fold increase of arsenic in serum and packed cells of chronic hemodialysis patients. Am J Nephrol. 1993;13(6):429-34. DOI: 10.1159/000168658
22. Mayer DR, Kosmus W, Pogglitsch H, et al. Essential trace elements in humans. Serum arsenic concentrations in hemodialysis patients in comparison to healthy controls. Biol Trace Elem Res. 1993;37(1):27-38
23. Yoshinori Miura, Keiko Nakai, Akira Suwabe, et al. Trace elements in renal disease and hemodialysis. Nuclear Instruments and Methods Physics Research B Beam interact Mater Atoms. 2002;189:443-49.
24. Pershagen G, Hast R, Lins LE, et al. Increased arsenic concentration in the bone marrow in chronic renal failure A contributor to Anaemia? Nephron. 1982;30(3):250-52. DOI: 10.1159/000182477.
25. Rucker D, Thadhani R, Tonelli M. Trace element status in hemodialysis patients. Semin Dial. 2010;23(4):389-95.
26. Schoen A, Beck B, Sharma R, Dube E. Arsenic toxicity at low doses: epidemiological and mode of action considerations. Toxicol Appl Pharmacol. 2004;198:253-67.
27. Zhang X, Cornelis R, De Kimpe J, et al. Accumulation of arsenic species in serum of patients with chronic renal disease. Clin Chem. 1996;42:1231-37.
28. Xue W, Wang Z, Chen Q, et al. High selenium status in individuals exposed to arsenic through coalburning in Shaanxi (PR of China) modulates antioxidant enzymes, heme oxygenase-1 and DNA damage. Clin Chem Acta. 2010;411:1312-18.
29. Huang Z, Pei Q, Sun G, et al. Low selenium status affects arsenic metabolites in an arsenic exposed population with skin lesions. Clin Chem Acta. 2008;387:139-44.
30. Zhang Xea. Determination of total arsenic in serum and packed cells of patients with renal insufficiency. Fresenius J Anal Chem. 1995;353:143-47.
31. Akinobu Ochi, Eiji Ishimura, Yoshihiro Tsujimoto, et al. Trace element in the hair of hemodialysis patients. Biol Trace Elem Res. 2011;143(2):825-834. Doi 10.1007/s12011-010-8948-y.
32. Michael Krachler, Gerhard Wirnsberger, Kurt J. Irgolic. Trace element status of hemodialysis patients. Boil Trace Elem Res. 1997;58:209-21.
33. Bing Chen, Ludwig V. Lamberts V, et al. Selenium, Lead, and Cadmium Levels in Renal Failure Patients in China. Biol Trace Elem Res. 131:1-12.
34. Skarupskiene I, Kuzminskis V, Adbrachmanovas O, et al. Influence of hemodialysis on changes of trace metals concentrations in blood of patients with end-stage renal failure. Medicina. (Kaunas) 2003;39(suppl 1): 131-38.
35. Lee SH, Huang JW, Hung KV, et al. Trace metals' abnormalities in hemodialysis patients, relationship with medications. Artificial Organs. 2000;24(11):841-44.
36. Navas-Acien A, Tellez-Plaza M, Crainceanu CM, et al. Blood cadmium and lead and chronic kidney disease in US adults: A joint analysis. Am J Epidemiol. 2009;170:1156-64.
37. Pietro Manuel Ferraro, Stafano Costanzi, Alessandro Naticchia, et al. Low level exposure to cadmium increases the risk of chronic kidney disease: analyses of the NHANES 1999-2006. BMC Public Health. 2010;10:304. doi:10.1186/1471-2458-10-304.
38. Barbier O, Jacquillet G, Tauc M, et al. Effect of heavy metals on and handling by the kidney. Nephron Physiol. 2005;99:105-110.
39. Tellez-Plaza M, Navas-Acien A, Crainceanu CM, et al. Cadmium exposure and hypertension in the 1999-2004 national health and nutrition examination survey (NHANES). Environ Health Perspect. 2008;116(1):51-56. doi: 10.1289/ehp.10764.
40. Gallagher CM, Kovach JS, Meliker J. Urinary cadmium and osteoporosis in US women ≥ 50 years of age: NHANES 1988-1994 and 1999-2004. Environ Health Perspect. 2008;116(10):1338-43.
41. Thomas LD, Hodgson S, Niewenhuijen M, et al. Early kidney damage in a population exposed to cadmium and other heavy metals. Environ Health Perspect. 2009;117(2):181-84.
42. Kazi TG, Jalbani N, Kazi N, et al. Estimation of toxic metals in scalp hair samples of chronic kidney patients. Biol Trace Elem Res. 2009;127:16-27.